Epigenetic Silencing through DNA and Histone Methylation of Fibroblast Growth Factor Receptor 2 in Neoplastic Pituitary Cells
- 31 May 2007
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 170 (5), 1618-1628
- https://doi.org/10.2353/ajpath.2007.061111
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Epigenetically Controlled Fibroblast Growth Factor Receptor 2 Signaling Imposes on the RAS/BRAF/Mitogen-Activated Protein Kinase Pathway to Modulate Thyroid Cancer ProgressionCancer Research, 2007
- Structural specificity in a FGF7‐affinity purified heparin octasaccharide required for formation of a complex with FGF7 and FGFR2IIIbJournal of Cellular Biochemistry, 2005
- Functions and regulations of fibroblast growth factor signaling during embryonic developmentDevelopmental Biology, 2005
- FGF Receptor Signaling at the Crossroads of Endocrine Homeostasis and TumorigenesisHormone and Metabolic Research, 2005
- Inactivation of RASSF1A tumor suppressor gene by aberrant promoter hypermethylation in human pituitary adenomasLaboratory Investigation, 2005
- Inhibition of human bladder tumour cell growth by fibroblast growth factor receptor 2b is independent of its kinase activity. Involvement of the carboxy-terminal region of the receptorOncogene, 2004
- A Stem Structure in Fibroblast Growth Factor Receptor 2 Transcripts Mediates Cell-Type-Specific Splicing by Approximating Intronic Control ElementsMolecular and Cellular Biology, 2003
- Pituitary Tumor AP-2α Recognizes a Cryptic Promoter in Intron 4 of Fibroblast Growth Factor Receptor 4Journal of Biological Chemistry, 2003
- Genome‐wide amplification and allelotyping of sporadic pituitary adenomas identify novel regions of genetic lossGenes, Chromosomes and Cancer, 2003
- Effects of an Rb mutation in the mouseNature, 1992